| 0 |
DRUG INEFFECTIVE |
48 |
| 1 |
APPLICATION SITE ERYTHEMA |
36 |
| 2 |
ERYTHEMA |
25 |
| 3 |
DRUG INTOLERANCE |
20 |
| 4 |
ADVERSE DRUG REACTION |
17 |
| 5 |
APPLICATION SITE EXFOLIATION |
17 |
| 6 |
APPLICATION SITE VESICLES |
16 |
| 7 |
OFF LABEL USE |
15 |
| 8 |
APPLICATION SITE PAIN |
13 |
| 9 |
PRURITUS |
12 |
| 10 |
APPLICATION SITE DRYNESS |
10 |
| 11 |
APPLICATION SITE PRURITUS |
10 |
| 12 |
BLISTER |
10 |
| 13 |
BURNING SENSATION |
8 |
| 14 |
PRODUCT USE ISSUE |
8 |
| 15 |
SKIN BURNING SENSATION |
8 |
| 16 |
APPLICATION SITE DISCOLOURATION |
7 |
| 17 |
APPLICATION SITE SCAB |
7 |
| 18 |
RASH |
7 |
| 19 |
SWELLING FACE |
7 |
| 20 |
APPLICATION SITE SWELLING |
6 |
| 21 |
HYPERSENSITIVITY |
6 |
| 22 |
NAUSEA |
6 |
| 23 |
PRODUCT PACKAGING QUANTITY ISSUE |
6 |
| 24 |
SKIN EXFOLIATION |
6 |
| 25 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
6 |
| 26 |
HEADACHE |
5 |
| 27 |
PAIN OF SKIN |
5 |
| 28 |
APPLICATION SITE RASH |
4 |
| 29 |
LIP SWELLING |
4 |
| 30 |
PAIN |
4 |
| 31 |
PARAESTHESIA |
4 |
| 32 |
POST INFLAMMATORY PIGMENTATION CHANGE |
4 |
| 33 |
SKIN REACTION |
4 |
| 34 |
SWOLLEN TONGUE |
4 |
| 35 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
| 36 |
ACTINIC KERATOSIS |
3 |
| 37 |
APPLICATION SITE IRRITATION |
3 |
| 38 |
BASAL CELL CARCINOMA |
3 |
| 39 |
CARDIOVASCULAR DISORDER |
3 |
| 40 |
DISCOMFORT |
3 |
| 41 |
INSOMNIA |
3 |
| 42 |
OCULAR HYPERAEMIA |
3 |
| 43 |
PHOTOSENSITIVITY REACTION |
3 |
| 44 |
PRODUCT DOSE OMISSION ISSUE |
3 |
| 45 |
RASH MACULAR |
3 |
| 46 |
SKIN IRRITATION |
3 |
| 47 |
SQUAMOUS CELL CARCINOMA |
3 |
| 48 |
APPLICATION SITE DISCHARGE |
2 |
| 49 |
ASTHENIA |
2 |
| 50 |
BLOOD PRESSURE FLUCTUATION |
2 |
| 51 |
CHAPPED LIPS |
2 |
| 52 |
CONDITION AGGRAVATED |
2 |
| 53 |
DERMATITIS |
2 |
| 54 |
DISEASE RECURRENCE |
2 |
| 55 |
DIZZINESS |
2 |
| 56 |
DRY SKIN |
2 |
| 57 |
EYE IRRITATION |
2 |
| 58 |
EYE PAIN |
2 |
| 59 |
EYE SWELLING |
2 |
| 60 |
HEART RATE INCREASED |
2 |
| 61 |
HERPES ZOSTER |
2 |
| 62 |
HYPERTENSION |
2 |
| 63 |
INCORRECT DOSE ADMINISTERED |
2 |
| 64 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
| 65 |
RASH PRURITIC |
2 |
| 66 |
SKIN TIGHTNESS |
2 |
| 67 |
STRESS |
2 |
| 68 |
SWELLING OF EYELID |
2 |
| 69 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
| 70 |
ULCER |
2 |
| 71 |
URTICARIA |
2 |
| 72 |
ABNORMAL BEHAVIOUR |
1 |
| 73 |
ADMINISTRATION SITE DISCOLOURATION |
1 |
| 74 |
ADVERSE EVENT |
1 |
| 75 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
| 76 |
ANAPHYLACTIC REACTION |
1 |
| 77 |
ANGIOEDEMA |
1 |
| 78 |
APPLICATION SITE ABSCESS |
1 |
| 79 |
APPLICATION SITE ALOPECIA |
1 |
| 80 |
APPLICATION SITE BRUISE |
1 |
| 81 |
APPLICATION SITE BURN |
1 |
| 82 |
APPLICATION SITE HAEMORRHAGE |
1 |
| 83 |
APPLICATION SITE HYPOAESTHESIA |
1 |
| 84 |
APPLICATION SITE INFLAMMATION |
1 |
| 85 |
APPLICATION SITE PARAESTHESIA |
1 |
| 86 |
APPLICATION SITE REACTION |
1 |
| 87 |
APPLICATION SITE WARMTH |
1 |
| 88 |
ARTHRALGIA |
1 |
| 89 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
| 90 |
ASPHYXIA |
1 |
| 91 |
BACK PAIN |
1 |
| 92 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
| 93 |
BRAIN FOG |
1 |
| 94 |
BRONCHOSPASM |
1 |
| 95 |
CHEMICAL BURN OF SKIN |
1 |
| 96 |
DEATH |
1 |
| 97 |
DERMAL CYST |
1 |
| 98 |
DIARRHOEA |
1 |
| 99 |
DIPLOPIA |
1 |
| 100 |
DISORIENTATION |
1 |
| 101 |
DIVERTICULUM INTESTINAL |
1 |
| 102 |
DRUG ERUPTION |
1 |
| 103 |
EATING DISORDER |
1 |
| 104 |
EMOTIONAL DISTRESS |
1 |
| 105 |
ERYSIPELAS |
1 |
| 106 |
EXPOSURE DURING PREGNANCY |
1 |
| 107 |
EYELID IRRITATION |
1 |
| 108 |
FACIAL PAIN |
1 |
| 109 |
FATIGUE |
1 |
| 110 |
FEELING GUILTY |
1 |
| 111 |
FEELING HOT |
1 |
| 112 |
FLUSHING |
1 |
| 113 |
GAIT DISTURBANCE |
1 |
| 114 |
GASTRIC ULCER |
1 |
| 115 |
HEAD DISCOMFORT |
1 |
| 116 |
HERPES SIMPLEX |
1 |
| 117 |
HOT FLUSH |
1 |
| 118 |
HYPERLIPIDAEMIA |
1 |
| 119 |
HYPOPHOSPHATAEMIA |
1 |
| 120 |
INFLAMMATION |
1 |
| 121 |
INJURY |
1 |
| 122 |
INTENTIONAL PRODUCT MISUSE |
1 |
| 123 |
LIP DRY |
1 |
| 124 |
LIP ERYTHEMA |
1 |
| 125 |
LIP PAIN |
1 |
| 126 |
MOUTH SWELLING |
1 |
| 127 |
MUSCULOSKELETAL STIFFNESS |
1 |
| 128 |
NASAL PRURITUS |
1 |
| 129 |
NEOPLASM |
1 |
| 130 |
NEURALGIA |
1 |
| 131 |
NODULE |
1 |
| 132 |
OEDEMA |
1 |
| 133 |
ORAL PAIN |
1 |
| 134 |
OSTEOPENIA |
1 |
| 135 |
PANCREATIC CYST |
1 |
| 136 |
PARADOXICAL DRUG REACTION |
1 |
| 137 |
PARAESTHESIA ORAL |
1 |
| 138 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
| 139 |
PERIORBITAL PAIN |
1 |
| 140 |
PHARYNGEAL SWELLING |
1 |
| 141 |
POIKILODERMA |
1 |
| 142 |
PRODUCT PACKAGING ISSUE |
1 |
| 143 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
| 144 |
PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT |
1 |
| 145 |
PSORIASIS |
1 |
| 146 |
PYREXIA |
1 |
| 147 |
RASH ERYTHEMATOUS |
1 |
| 148 |
RECALL PHENOMENON |
1 |
| 149 |
RHINALGIA |
1 |
| 150 |
ROSACEA |
1 |
| 151 |
SCAB |
1 |
| 152 |
SCAR |
1 |
| 153 |
SECOND DEGREE CHEMICAL BURN OF SKIN |
1 |
| 154 |
SECOND PRIMARY MALIGNANCY |
1 |
| 155 |
SEROUS RETINAL DETACHMENT |
1 |
| 156 |
SKIN DISCOLOURATION |
1 |
| 157 |
SKIN DISORDER |
1 |
| 158 |
SKIN NECROSIS |
1 |
| 159 |
SKIN PLAQUE |
1 |
| 160 |
SKIN TEXTURE ABNORMAL |
1 |
| 161 |
SKIN WRINKLING |
1 |
| 162 |
SQUAMOUS CELL CARCINOMA OF SKIN |
1 |
| 163 |
SUICIDAL IDEATION |
1 |
| 164 |
SWELLING |
1 |
| 165 |
SWELLING OF NOSE |
1 |
| 166 |
TASTE DISORDER |
1 |
| 167 |
TENDERNESS |
1 |
| 168 |
UROSEPSIS |
1 |
| 169 |
VERTIGO |
1 |
| 170 |
VIRAL INFECTION |
1 |
| 171 |
WOUND |
1 |